Project Name：
Phase II of the monoclonal antibody development pilot project
Project Description：
The total construction area spans 6,500 square meters, including 2,200 square meters of clean zones meeting Class B+C+D standards. The project encompasses a full-cycle service chain from infrastructure development to cleanroom construction, HVAC systems, and process engineering. With reliable engineering quality and strict schedule adherence, ELCO delivered the project on time, effectively supporting monoclonal antibody R&D progress.